Skip to main content
Erschienen in: Clinical Research in Cardiology 5/2016

07.11.2015 | Original Paper

Prognostic role of N-terminal pro-brain natriuretic peptide in asymptomatic hypertensive and diabetic patients in primary care: impact of age and gender

Results from the PROBE-HF study

verfasst von: Piercarlo Ballo, Irene Betti, Alessandro Barchielli, Daniela Balzi, Gabriele Castelli, Leonardo De Luca, Mihai Gheorghiade, Alfredo Zuppiroli

Erschienen in: Clinical Research in Cardiology | Ausgabe 5/2016

Einloggen, um Zugang zu erhalten

Abstract

Background

The association between natriuretic peptides and clinical outcome in asymptomatic hypertensive and diabetic patients with no clinical evidence of heart failure (HF) is still unclear. We assessed the prognostic value of NT-pro BNP, and its interactions with age and gender, in a cohort of asymptomatic, stage A/B HF hypertensive and diabetic patients enrolled in primary care.

Methods

NT-proBNP was measured in 1012 asymptomatic subjects with systemic hypertension and/or type-2 diabetes (age 66.6 ± 7.8 years, 48 % males) with no clinical evidence of HF. Patients were prospectively followed over 49.8 ± 6.7 months for the development of cardiac death, HF hospitalization, and nonfatal myocardial infarction.

Results

Patients with NT-proBNP above the 80th age- and gender-specific percentile showed a threefold risk of events as compared to those with NT-proBNP under this cut-off [hazard ratio 3.2 (2.6–8.3), p < 0.0001]. In multivariable analysis, NT-proBNP added independent and incremental prognostic information to a predictive model including established risk factors (p < 0.0001). After stratification by age, increased NT-proBNP predicted outcome among patients in the second and third age tertiles, but not among those in the first tertile. Increased NT-proBNP was associated with a 3.6-fold risk in women and a 2.9-fold risk in men. Addition of the gender-NT-proBNP interaction to prognostic models further improved prediction of events (p = 0.014).

Conclusions

NT-proBNP measurement adds independent and incremental information for the prediction of clinical outcome in asymptomatic, stage A-B HF hypertensive and diabetic patients taken from primary care. This prognostic value might be further evident in the elderly and among women.
Literatur
1.
Zurück zum Zitat Schneider HG, Lam L, Lokuge A et al (2009) B-type natriuretic peptide testing, clinical outcomes, and health services use in emergency department patients with dyspnea: a randomized trial. Ann Intern Med 150:365–371CrossRefPubMed Schneider HG, Lam L, Lokuge A et al (2009) B-type natriuretic peptide testing, clinical outcomes, and health services use in emergency department patients with dyspnea: a randomized trial. Ann Intern Med 150:365–371CrossRefPubMed
2.
Zurück zum Zitat Rosenberg J, Schou M, Gustafsson F, Badskjaer J, Hildebrandt P (2009) Prognostic threshold levels of NT-proBNP testing in primary care. Eur Heart J 30:66–73CrossRefPubMed Rosenberg J, Schou M, Gustafsson F, Badskjaer J, Hildebrandt P (2009) Prognostic threshold levels of NT-proBNP testing in primary care. Eur Heart J 30:66–73CrossRefPubMed
3.
Zurück zum Zitat Frankenstein L, Remppis A, Nelles M et al (2008) Relation of N-terminal pro-brain natriuretic peptide levels and their prognostic power in chronic stable heart failure to obesity status. Eur Heart J 29:2634–2640CrossRefPubMed Frankenstein L, Remppis A, Nelles M et al (2008) Relation of N-terminal pro-brain natriuretic peptide levels and their prognostic power in chronic stable heart failure to obesity status. Eur Heart J 29:2634–2640CrossRefPubMed
4.
Zurück zum Zitat Vazquez R, Bayes-Genis A, Cygankiewicz I, MUSIC Investigators et al (2009) The MUSIC Risk score: a simple method for predicting mortality in ambulatory patients with chronic heart failure. Eur Heart J 30:1088–1096 Vazquez R, Bayes-Genis A, Cygankiewicz I, MUSIC Investigators et al (2009) The MUSIC Risk score: a simple method for predicting mortality in ambulatory patients with chronic heart failure. Eur Heart J 30:1088–1096
5.
Zurück zum Zitat Wang TJ, Larson MG, Levy D et al (2004) Plasma natriuretic peptide levels and the risk of cardiovascular events and death. N Engl J Med 350:655–663 Wang TJ, Larson MG, Levy D et al (2004) Plasma natriuretic peptide levels and the risk of cardiovascular events and death. N Engl J Med 350:655–663
6.
Zurück zum Zitat Leistner DM, Klotsche J, Pieper L et al (2013) Prognostic value of NT-pro-BNP and hs-CRP for risk stratification in primary care: results from the population-based DETECT study. Clin Res Cardiol 102:259–268CrossRefPubMed Leistner DM, Klotsche J, Pieper L et al (2013) Prognostic value of NT-pro-BNP and hs-CRP for risk stratification in primary care: results from the population-based DETECT study. Clin Res Cardiol 102:259–268CrossRefPubMed
7.
Zurück zum Zitat Linssen GC, Bakker SJ, Voors AA et al (2010) N-terminal pro-B-type natriuretic peptide is an independent predictor of cardiovascular morbidity and mortality in the general population. Eur Heart J 31:120–127CrossRefPubMed Linssen GC, Bakker SJ, Voors AA et al (2010) N-terminal pro-B-type natriuretic peptide is an independent predictor of cardiovascular morbidity and mortality in the general population. Eur Heart J 31:120–127CrossRefPubMed
8.
Zurück zum Zitat Kara K, Mahabadi AA, Geisel MH et al (2014) B-type natriuretic peptide: distribution in the general population and the association with major cardiovascular and coronary events–the Heinz Nixdorf recall study. Clin Res Cardiol 103:125–132CrossRefPubMed Kara K, Mahabadi AA, Geisel MH et al (2014) B-type natriuretic peptide: distribution in the general population and the association with major cardiovascular and coronary events–the Heinz Nixdorf recall study. Clin Res Cardiol 103:125–132CrossRefPubMed
9.
Zurück zum Zitat Klaar U, Gabriel H, Bergler-Klein J et al (2011) Prognostic value of serial B-type natriuretic peptide measurement in asymptomatic organic mitral regurgitation. Eur J Heart Fail 13:163–169CrossRefPubMed Klaar U, Gabriel H, Bergler-Klein J et al (2011) Prognostic value of serial B-type natriuretic peptide measurement in asymptomatic organic mitral regurgitation. Eur J Heart Fail 13:163–169CrossRefPubMed
10.
Zurück zum Zitat Daniels LB, Clopton P, Jiang K, Greenberg B, Maisel AS (2010) Prognosis of stage A or B heart failure patients with elevated B-type natriuretic peptide levels. J Card Fail 16:93–98CrossRefPubMed Daniels LB, Clopton P, Jiang K, Greenberg B, Maisel AS (2010) Prognosis of stage A or B heart failure patients with elevated B-type natriuretic peptide levels. J Card Fail 16:93–98CrossRefPubMed
11.
Zurück zum Zitat Huelsmann M, Neuhold S, Strunk G et al (2008) NT-proBNP has a high negative predictive value to rule-out short-term cardiovascular events in patients with diabetes mellitus. Eur Heart J 29:2259–2264CrossRefPubMed Huelsmann M, Neuhold S, Strunk G et al (2008) NT-proBNP has a high negative predictive value to rule-out short-term cardiovascular events in patients with diabetes mellitus. Eur Heart J 29:2259–2264CrossRefPubMed
12.
Zurück zum Zitat Pedersen F, Raymond I, Kistorp C, Sandgaard N, Jacobsen P, Hildebrandt P (2005) N-terminal pro-brain natriuretic peptide in arterial hypertension: a valuable prognostic marker of cardiovascular events. J Card Fail 11:S70–S75CrossRefPubMed Pedersen F, Raymond I, Kistorp C, Sandgaard N, Jacobsen P, Hildebrandt P (2005) N-terminal pro-brain natriuretic peptide in arterial hypertension: a valuable prognostic marker of cardiovascular events. J Card Fail 11:S70–S75CrossRefPubMed
13.
Zurück zum Zitat Loke I, Squire IB, Davies JE, Ng LL (2003) Reference ranges for natriuretic peptides for diagnostic use are dependent on age, gender and heart rate. Eur J Heart Fail 5:599–606CrossRefPubMed Loke I, Squire IB, Davies JE, Ng LL (2003) Reference ranges for natriuretic peptides for diagnostic use are dependent on age, gender and heart rate. Eur J Heart Fail 5:599–606CrossRefPubMed
14.
Zurück zum Zitat Redfield MM, Rodeheffer RJ, Jacobsen SJ, Mahoney DW, Bailey KR, Burnett JC Jr (2002) Plasma brain natriuretic peptide concentration: impact of age and gender. J Am Coll Cardiol 40:976–982CrossRefPubMed Redfield MM, Rodeheffer RJ, Jacobsen SJ, Mahoney DW, Bailey KR, Burnett JC Jr (2002) Plasma brain natriuretic peptide concentration: impact of age and gender. J Am Coll Cardiol 40:976–982CrossRefPubMed
15.
Zurück zum Zitat Betti I, Castelli G, Barchielli A et al (2009) The role of N-terminal PRO-brain natriuretic peptide and echocardiography for screening asymptomatic left ventricular dysfunction in a population at high risk for heart failure.The PROBE-HF study. J Card Fail 15:377–384CrossRefPubMed Betti I, Castelli G, Barchielli A et al (2009) The role of N-terminal PRO-brain natriuretic peptide and echocardiography for screening asymptomatic left ventricular dysfunction in a population at high risk for heart failure.The PROBE-HF study. J Card Fail 15:377–384CrossRefPubMed
16.
Zurück zum Zitat Yancy CW, Jessup M, Bozkurt B et al (2013) ACCF/AHA guideline for the management of heart failure: a report of the American college of cardiology foundation/American heart association task force on practice guidelines. Circulation 128:e240–e327CrossRefPubMed Yancy CW, Jessup M, Bozkurt B et al (2013) ACCF/AHA guideline for the management of heart failure: a report of the American college of cardiology foundation/American heart association task force on practice guidelines. Circulation 128:e240–e327CrossRefPubMed
17.
Zurück zum Zitat Mancia G, Fagard R, Narkiewicz K et al (2013) ESH/ESC guidelines for the management of arterial hypertension: the task force for the management of arterial hypertension of the European society of hypertension (ESH) and of the European society of cardiology (ESC). Eur Heart J 34:2159–2219CrossRefPubMed Mancia G, Fagard R, Narkiewicz K et al (2013) ESH/ESC guidelines for the management of arterial hypertension: the task force for the management of arterial hypertension of the European society of hypertension (ESH) and of the European society of cardiology (ESC). Eur Heart J 34:2159–2219CrossRefPubMed
18.
Zurück zum Zitat World Health Organization (1999) Definition, diagnosis and classification of diabetes mellitus and its complications. Part 1: diagnosis and classification of diabetes mellitus. World Health Org, Geneva World Health Organization (1999) Definition, diagnosis and classification of diabetes mellitus and its complications. Part 1: diagnosis and classification of diabetes mellitus. World Health Org, Geneva
19.
Zurück zum Zitat Lang RM, Badano LP, Mor-Avi V et al (2015) Recommendations for cardiac chamber quantification by echocardiography in adults: an update from the American society of echocardiography and the European association of cardiovascular imaging. Eur Heart J Cardiovasc Imaging 16:233–270CrossRefPubMed Lang RM, Badano LP, Mor-Avi V et al (2015) Recommendations for cardiac chamber quantification by echocardiography in adults: an update from the American society of echocardiography and the European association of cardiovascular imaging. Eur Heart J Cardiovasc Imaging 16:233–270CrossRefPubMed
20.
Zurück zum Zitat Lang RM, Bierig M, Devereux RB et al (2005) Recommendations for chamber quantification: a report from the American society of echocardiography’s guidelines and standards committee and the chamber quantification writing group, developed in conjunction with the european association of echocardiography, a branch of the European society of cardiology. J Am Soc Echocardiogr 18:1440–1463CrossRefPubMed Lang RM, Bierig M, Devereux RB et al (2005) Recommendations for chamber quantification: a report from the American society of echocardiography’s guidelines and standards committee and the chamber quantification writing group, developed in conjunction with the european association of echocardiography, a branch of the European society of cardiology. J Am Soc Echocardiogr 18:1440–1463CrossRefPubMed
21.
Zurück zum Zitat Nagueh SF, Appleton CP, Gillebert TC et al (2009) Recommendations for the evaluation of left ventricular diastolic function by echocardiography. Eur J Echocardiogr 10:165–193CrossRefPubMed Nagueh SF, Appleton CP, Gillebert TC et al (2009) Recommendations for the evaluation of left ventricular diastolic function by echocardiography. Eur J Echocardiogr 10:165–193CrossRefPubMed
22.
Zurück zum Zitat Vahanian A, Baumgartner H, Bax J et al (2007) The task force on the management of valvular heart disease of the European society of cardiology. Eur Heart J 28:230–268PubMed Vahanian A, Baumgartner H, Bax J et al (2007) The task force on the management of valvular heart disease of the European society of cardiology. Eur Heart J 28:230–268PubMed
23.
Zurück zum Zitat Collinson PO, Barnes SC, Gaze DC, Galasko G, Lahiri A, Senior R (2004) Analytical performance of the N terminal pro B type natriuretic peptide (NT-proBNP) assay on the Elecsys 1010 and 2010 analysers. Eur J Heart Fail 6:365–368CrossRefPubMed Collinson PO, Barnes SC, Gaze DC, Galasko G, Lahiri A, Senior R (2004) Analytical performance of the N terminal pro B type natriuretic peptide (NT-proBNP) assay on the Elecsys 1010 and 2010 analysers. Eur J Heart Fail 6:365–368CrossRefPubMed
24.
Zurück zum Zitat McKie PM, Cataliotti A, Lahr BD et al (2010) The prognostic value of N-terminal pro-B-type natriuretic peptide for death and cardiovascular events in healthy normal and stage A/B heart failure subjects. J Am Coll Cardiol 55:2140–2147CrossRefPubMedPubMedCentral McKie PM, Cataliotti A, Lahr BD et al (2010) The prognostic value of N-terminal pro-B-type natriuretic peptide for death and cardiovascular events in healthy normal and stage A/B heart failure subjects. J Am Coll Cardiol 55:2140–2147CrossRefPubMedPubMedCentral
25.
Zurück zum Zitat Kistorp C, Raymond I, Pedersen F, Gustafsson F, Faber J, Hildebrandt P (2005) N-terminal pro-brain natriuretic peptide, C-reactive protein, and urinary albumin levels as predictors of mortality and cardiovascular events in older adults. JAMA 293:1609–1616CrossRefPubMed Kistorp C, Raymond I, Pedersen F, Gustafsson F, Faber J, Hildebrandt P (2005) N-terminal pro-brain natriuretic peptide, C-reactive protein, and urinary albumin levels as predictors of mortality and cardiovascular events in older adults. JAMA 293:1609–1616CrossRefPubMed
26.
Zurück zum Zitat Onodera M, Nakamura M, Tanaka F et al (2012) Plasma B-type natriuretic peptide is useful for cardiovascular risk assessment in community-based diabetes subjects: comparison with albuminuria. Int Heart J 53:176–181CrossRefPubMed Onodera M, Nakamura M, Tanaka F et al (2012) Plasma B-type natriuretic peptide is useful for cardiovascular risk assessment in community-based diabetes subjects: comparison with albuminuria. Int Heart J 53:176–181CrossRefPubMed
27.
Zurück zum Zitat Januzzi JL, van Kimmenade R, Lainchbury J et al (2006) NT-proBNP testing for diagnosis and short-term prognosis in acute destabilized heart failure: an international pooled analysis of 1256 patients: the International Collaborative of NT-proBNP Study. Eur Heart J 27:330–337CrossRefPubMed Januzzi JL, van Kimmenade R, Lainchbury J et al (2006) NT-proBNP testing for diagnosis and short-term prognosis in acute destabilized heart failure: an international pooled analysis of 1256 patients: the International Collaborative of NT-proBNP Study. Eur Heart J 27:330–337CrossRefPubMed
28.
Zurück zum Zitat Rodeheffer RJ, Jacobsen SJ, Gersh BJ et al (1993) The incidence and prevalence of congestive heart failure in Rochester, Minnesota. Mayo Clin Proc 68:1143e50 Rodeheffer RJ, Jacobsen SJ, Gersh BJ et al (1993) The incidence and prevalence of congestive heart failure in Rochester, Minnesota. Mayo Clin Proc 68:1143e50
29.
Zurück zum Zitat Ho KK, Anderson KM, Kannel WB, Grossman W, Levy D (1993) Survival after the onset of congestive heart failure in Framingham heart study subjects. Circulation 88:107e15 Ho KK, Anderson KM, Kannel WB, Grossman W, Levy D (1993) Survival after the onset of congestive heart failure in Framingham heart study subjects. Circulation 88:107e15
30.
Zurück zum Zitat Dini FL, Whalley G, Poppe K et al (2009) Plasma N-terminal protype-B natriuretic peptide and restrictive mitral flow to risk-stratify patients with stage B heart failure. Clin Cardiol 32:711–717CrossRefPubMed Dini FL, Whalley G, Poppe K et al (2009) Plasma N-terminal protype-B natriuretic peptide and restrictive mitral flow to risk-stratify patients with stage B heart failure. Clin Cardiol 32:711–717CrossRefPubMed
31.
Zurück zum Zitat Shlipak MG, Ix JH, Bibbins-Domingo K, Lin F, Whooley MA (2008) Biomarkers to predict recurrent cardiovascular disease: the heart and soul study. Am J Med 121:50–57CrossRefPubMedPubMedCentral Shlipak MG, Ix JH, Bibbins-Domingo K, Lin F, Whooley MA (2008) Biomarkers to predict recurrent cardiovascular disease: the heart and soul study. Am J Med 121:50–57CrossRefPubMedPubMedCentral
32.
Zurück zum Zitat Bibbins-Domingo K, Gupta R, Na B, Wu AH, Schiller NB, Whooley MA (2007) N-terminal fragment of the prohormone brain-type natriuretic peptide (NT-proBNP), cardiovascular events, and mortality in patients with stable coronary heart disease. JAMA 297:169–176CrossRefPubMedPubMedCentral Bibbins-Domingo K, Gupta R, Na B, Wu AH, Schiller NB, Whooley MA (2007) N-terminal fragment of the prohormone brain-type natriuretic peptide (NT-proBNP), cardiovascular events, and mortality in patients with stable coronary heart disease. JAMA 297:169–176CrossRefPubMedPubMedCentral
33.
Zurück zum Zitat Fradley MG, Larson MG, Cheng S et al (2011) Reference limits for N-terminal-pro-B-type natriuretic peptide in healthy individuals (from the Framingham heart study). Am J Cardiol 108:1341–1345CrossRefPubMedPubMedCentral Fradley MG, Larson MG, Cheng S et al (2011) Reference limits for N-terminal-pro-B-type natriuretic peptide in healthy individuals (from the Framingham heart study). Am J Cardiol 108:1341–1345CrossRefPubMedPubMedCentral
34.
Zurück zum Zitat Gustafsson F, Steensgaard-Hansen F, Badskjær J, Poulsen AH, Corell P, Hildebrandt P (2005) Diagnostic and prognostic performance of N-terminal ProBNP in primary care patients with suspected heart failure. J Card Fail 11:S15–S20CrossRefPubMed Gustafsson F, Steensgaard-Hansen F, Badskjær J, Poulsen AH, Corell P, Hildebrandt P (2005) Diagnostic and prognostic performance of N-terminal ProBNP in primary care patients with suspected heart failure. J Card Fail 11:S15–S20CrossRefPubMed
35.
Zurück zum Zitat Hildebrandt P, Collinson PO, Doughty RN et al (2010) Age-dependent values of N-terminal pro-B-type natriuretic peptide are superior to a single cut-point for ruling out suspected systolic dysfunction in primary care. Eur Heart J 31:1881–1889CrossRefPubMed Hildebrandt P, Collinson PO, Doughty RN et al (2010) Age-dependent values of N-terminal pro-B-type natriuretic peptide are superior to a single cut-point for ruling out suspected systolic dysfunction in primary care. Eur Heart J 31:1881–1889CrossRefPubMed
36.
Zurück zum Zitat Nielsen OW, Kirk V, Bay M, Boesgaard S, Nielsen H (2004) Value of N-terminal pro brain natriuretic peptide in the elderly: data from the prospective Copenhagen Hospital heart failure study (CHHF). Eur J Heart Fail 6:275–279CrossRefPubMed Nielsen OW, Kirk V, Bay M, Boesgaard S, Nielsen H (2004) Value of N-terminal pro brain natriuretic peptide in the elderly: data from the prospective Copenhagen Hospital heart failure study (CHHF). Eur J Heart Fail 6:275–279CrossRefPubMed
37.
Zurück zum Zitat Frankenstein L, Clark AL, Goode K et al (2009) The prognostic value of individual NT-proBNP values in chronic heart failure does not change with advancing age. Heart 95:825–829CrossRefPubMed Frankenstein L, Clark AL, Goode K et al (2009) The prognostic value of individual NT-proBNP values in chronic heart failure does not change with advancing age. Heart 95:825–829CrossRefPubMed
38.
Zurück zum Zitat Olsen MH, Hansen TW, Christensen MK et al (2008) Cardiovascular risk prediction by N-terminal pro brain natriuretic peptide and high sensitivity C-reactive protein is affected by age and sex. J Hypertens 26:26–34CrossRefPubMed Olsen MH, Hansen TW, Christensen MK et al (2008) Cardiovascular risk prediction by N-terminal pro brain natriuretic peptide and high sensitivity C-reactive protein is affected by age and sex. J Hypertens 26:26–34CrossRefPubMed
39.
Zurück zum Zitat Franke J, Lindmark A, Hochadel M et al (2015) Gender aspects in clinical presentation and prognostication of chronic heart failure according to NT-proBNP and the heart failure survival score. Clin Res Cardiol 104:334–341CrossRefPubMed Franke J, Lindmark A, Hochadel M et al (2015) Gender aspects in clinical presentation and prognostication of chronic heart failure according to NT-proBNP and the heart failure survival score. Clin Res Cardiol 104:334–341CrossRefPubMed
40.
Zurück zum Zitat Kara K, Lehmann N, Neumann T et al (2015) NT-proBNP is superior to BNP for predicting first cardiovascular events in the general population: the Heinz Nixdorf recall study. Int J Cardiol 183:155–161CrossRefPubMed Kara K, Lehmann N, Neumann T et al (2015) NT-proBNP is superior to BNP for predicting first cardiovascular events in the general population: the Heinz Nixdorf recall study. Int J Cardiol 183:155–161CrossRefPubMed
41.
Zurück zum Zitat Christ M, Laule-Kilian K, Hochholzer W et al (2006) Gender-specific risk stratification with B-type natriuretic peptide levels in patients with acute dyspnea: insights from the B-type natriuretic peptide for acute shortness of breath evaluation study. J Am Coll Cardiol 48:1808–1812CrossRefPubMed Christ M, Laule-Kilian K, Hochholzer W et al (2006) Gender-specific risk stratification with B-type natriuretic peptide levels in patients with acute dyspnea: insights from the B-type natriuretic peptide for acute shortness of breath evaluation study. J Am Coll Cardiol 48:1808–1812CrossRefPubMed
42.
Zurück zum Zitat Nakamura M, Tanaka F, Onoda T et al (2010) Gender-specific risk stratification with plasma B-type natriuretic peptide for future onset of congestive heart failure and mortality in the Japanese general population. Int J Cardiol 143:124–129CrossRefPubMed Nakamura M, Tanaka F, Onoda T et al (2010) Gender-specific risk stratification with plasma B-type natriuretic peptide for future onset of congestive heart failure and mortality in the Japanese general population. Int J Cardiol 143:124–129CrossRefPubMed
44.
Zurück zum Zitat Ogah OS, Davison BA, Sliwa K et al (2015) Gender differences in clinical characteristics and outcome of acute heart failure in sub-Saharan Africa: results of the THESUS-HF study. Clin Res Cardiol 104:481–490CrossRefPubMed Ogah OS, Davison BA, Sliwa K et al (2015) Gender differences in clinical characteristics and outcome of acute heart failure in sub-Saharan Africa: results of the THESUS-HF study. Clin Res Cardiol 104:481–490CrossRefPubMed
45.
Zurück zum Zitat Meyer S, Brouwers FP, Voors AA et al (2015) Sex differences in new-onset heart failure. Clin Res Cardiol 104:342–350CrossRefPubMed Meyer S, Brouwers FP, Voors AA et al (2015) Sex differences in new-onset heart failure. Clin Res Cardiol 104:342–350CrossRefPubMed
46.
Zurück zum Zitat Ballo P, Betti I, Barchielli A et al (2013) Body mass index, gender, and clinical outcome among hypertensive and diabetic patients with stage A/B heart failure. Obesity 21:E500–E507PubMed Ballo P, Betti I, Barchielli A et al (2013) Body mass index, gender, and clinical outcome among hypertensive and diabetic patients with stage A/B heart failure. Obesity 21:E500–E507PubMed
47.
Zurück zum Zitat Schocken DD, Benjamin EJ, Fonarow GC et al (2008) Prevention of heart failure: a scientific statement from the American heart association councils on epidemiology and prevention, clinical cardiology, cardiovascular nursing, and high blood pressure research; quality of care and outcomes research interdisciplinary working group; and functional genomics and translational biology interdisciplinary working group. Circulation 117:2544e65 Schocken DD, Benjamin EJ, Fonarow GC et al (2008) Prevention of heart failure: a scientific statement from the American heart association councils on epidemiology and prevention, clinical cardiology, cardiovascular nursing, and high blood pressure research; quality of care and outcomes research interdisciplinary working group; and functional genomics and translational biology interdisciplinary working group. Circulation 117:2544e65
48.
Zurück zum Zitat Daugherty SL, Masoudi FA, Ellis JL et al (2011) Age-dependent gender differences in hypertension management. J Hypertens 29:1005–1011 Daugherty SL, Masoudi FA, Ellis JL et al (2011) Age-dependent gender differences in hypertension management. J Hypertens 29:1005–1011
49.
Zurück zum Zitat Homko CJ, Zamora L, Santamore WP, Kashem A, McConnell T, Bove AA (2010) Gender differences in cardiovascular risk factors and risk perception among individuals with diabetes. Diabetes Educ 36:483–488CrossRefPubMed Homko CJ, Zamora L, Santamore WP, Kashem A, McConnell T, Bove AA (2010) Gender differences in cardiovascular risk factors and risk perception among individuals with diabetes. Diabetes Educ 36:483–488CrossRefPubMed
50.
Zurück zum Zitat Scirica BM, Morrow DA, Bode C et al (2010) Patients with acute coronary syndromes and elevated levels of natriuretic peptides: the results of the AVANT GARDE-TIMI 43 Trial. Eur Heart J 31:1993–2005CrossRefPubMed Scirica BM, Morrow DA, Bode C et al (2010) Patients with acute coronary syndromes and elevated levels of natriuretic peptides: the results of the AVANT GARDE-TIMI 43 Trial. Eur Heart J 31:1993–2005CrossRefPubMed
51.
Zurück zum Zitat Staub D, Nusbaumer C, Zellweger MJ et al (2006) Use of B-type natriuretic peptide in the detection of myocardial ischemia. Am Heart J 151:1223–1230CrossRefPubMed Staub D, Nusbaumer C, Zellweger MJ et al (2006) Use of B-type natriuretic peptide in the detection of myocardial ischemia. Am Heart J 151:1223–1230CrossRefPubMed
52.
Zurück zum Zitat Cosson E, Nguyen MT, Pham I, Pontet M, Nitenberg A, Valensi P (2009) N-terminal pro-B-type natriuretic peptide: an independent marker for coronary artery disease in asymptomatic diabetic patients. Diabet Med 26:872–879CrossRefPubMed Cosson E, Nguyen MT, Pham I, Pontet M, Nitenberg A, Valensi P (2009) N-terminal pro-B-type natriuretic peptide: an independent marker for coronary artery disease in asymptomatic diabetic patients. Diabet Med 26:872–879CrossRefPubMed
53.
Zurück zum Zitat Poulsen MK, Henriksen JE, Vach W et al (2010) Identification of asymptomatic type 2 diabetes mellitus patients with a low, intermediate and high risk of ischaemic heart disease: is there an algorithm? Diabetologia 53:659–667CrossRefPubMed Poulsen MK, Henriksen JE, Vach W et al (2010) Identification of asymptomatic type 2 diabetes mellitus patients with a low, intermediate and high risk of ischaemic heart disease: is there an algorithm? Diabetologia 53:659–667CrossRefPubMed
54.
Zurück zum Zitat Singh HS, Bibbins-Domingo K, Ali S, Wu AH, Schiller NB, Whooley MA (2009) N-terminal pro-B-type natriuretic peptide and inducible ischemia in the Heart and Soul Study. Clin Cardiol 32:447–453CrossRefPubMedPubMedCentral Singh HS, Bibbins-Domingo K, Ali S, Wu AH, Schiller NB, Whooley MA (2009) N-terminal pro-B-type natriuretic peptide and inducible ischemia in the Heart and Soul Study. Clin Cardiol 32:447–453CrossRefPubMedPubMedCentral
55.
Zurück zum Zitat Wiersma JJ, van der Zee PM, van Straalen JP et al (2009) NT-pro-BNP is associated with inducible myocardial ischemia in mildly symptomatic type 2 diabetic patients. Int J Cardiol 145:295–296CrossRefPubMed Wiersma JJ, van der Zee PM, van Straalen JP et al (2009) NT-pro-BNP is associated with inducible myocardial ischemia in mildly symptomatic type 2 diabetic patients. Int J Cardiol 145:295–296CrossRefPubMed
56.
Zurück zum Zitat Kováts T, Wettstein A, Nagy E, Tomcsányi J (2008) Bradycardia can induce increased serum natriuretic peptide-level. Int J Cardiol 123:e43–e44CrossRefPubMed Kováts T, Wettstein A, Nagy E, Tomcsányi J (2008) Bradycardia can induce increased serum natriuretic peptide-level. Int J Cardiol 123:e43–e44CrossRefPubMed
57.
Zurück zum Zitat Baggish AL, van Kimmenade RR, Januzzi JL Jr (2008) The differential diagnosis of an elevated amino-terminal pro-B-type natriuretic peptide level. Am J Cardiol 101:43–48CrossRefPubMed Baggish AL, van Kimmenade RR, Januzzi JL Jr (2008) The differential diagnosis of an elevated amino-terminal pro-B-type natriuretic peptide level. Am J Cardiol 101:43–48CrossRefPubMed
58.
Zurück zum Zitat Kováts T, Tomcsányi J (2009) Bradycardia and B-type natriuretic peptide. Int J Cardiol 145:238–239CrossRef Kováts T, Tomcsányi J (2009) Bradycardia and B-type natriuretic peptide. Int J Cardiol 145:238–239CrossRef
59.
Zurück zum Zitat Sinning C, Kieback A, Wild PS et al (2014) Association of multiple biomarkers and classical risk factors with early carotid atherosclerosis: results from the Gutenberg Health Study. Clin Res Cardiol 103:477–485CrossRefPubMed Sinning C, Kieback A, Wild PS et al (2014) Association of multiple biomarkers and classical risk factors with early carotid atherosclerosis: results from the Gutenberg Health Study. Clin Res Cardiol 103:477–485CrossRefPubMed
61.
Zurück zum Zitat Friões F, Lourenço P, Laszczynska O et al (2015) Prognostic value of sST2 added to BNP in acute heart failure with preserved or reduced ejection fraction. Clin Res Cardiol 104:491–499CrossRefPubMed Friões F, Lourenço P, Laszczynska O et al (2015) Prognostic value of sST2 added to BNP in acute heart failure with preserved or reduced ejection fraction. Clin Res Cardiol 104:491–499CrossRefPubMed
62.
Zurück zum Zitat Bayes-Genis A, Ordonez-Llanos J (2015) Multiple biomarker strategies for risk stratification in heart failure. Clin Chim Acta 443:120–125CrossRefPubMed Bayes-Genis A, Ordonez-Llanos J (2015) Multiple biomarker strategies for risk stratification in heart failure. Clin Chim Acta 443:120–125CrossRefPubMed
Metadaten
Titel
Prognostic role of N-terminal pro-brain natriuretic peptide in asymptomatic hypertensive and diabetic patients in primary care: impact of age and gender
Results from the PROBE-HF study
verfasst von
Piercarlo Ballo
Irene Betti
Alessandro Barchielli
Daniela Balzi
Gabriele Castelli
Leonardo De Luca
Mihai Gheorghiade
Alfredo Zuppiroli
Publikationsdatum
07.11.2015
Verlag
Springer Berlin Heidelberg
Erschienen in
Clinical Research in Cardiology / Ausgabe 5/2016
Print ISSN: 1861-0684
Elektronische ISSN: 1861-0692
DOI
https://doi.org/10.1007/s00392-015-0937-x

Weitere Artikel der Ausgabe 5/2016

Clinical Research in Cardiology 5/2016 Zur Ausgabe

Update Kardiologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.